Trial Profile
Prograf (tacrolimus) as secondary intervention vs. continuation of cyclosporine [ciclosporin] in patients at risk for chronic renal allograft failure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Ciclosporin
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 05 Apr 2008 New trial record.